• Technology and Data
  • Front End Sales and Marketing
  • Allergy
  • HIV
  • Women's Health
  • Migraine
  • Compounding
  • Continuous Glucose Monitoring
  • Mental Health Awareness
  • Veterinary Pharmacy
  • CBD
  • Infectious Disease
  • Eye Health
  • Digestive Health
  • Biosimilars
  • Influenza
  • Shingles
  • COPD Management
  • Pediatrics
  • Generics
  • Pain Management
  • COVID-19
  • Immunization
  • Oncology
  • Anticoagulants
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Respiratory
  • Heart Health
  • Cardiovascular Clinical Consult

News Roundup: US Drug Overdose Deaths Reach Record High, Study Examines High-Dose Buprenorphine Therapy in Emergency Departments


Here’s a roundup of the latest news coverage from Drug Topics®.

Don’t waste time digging through articles to find the most up-to-date and important news. Drug Topics® has you covered with our weekly news roundup of the latest pharmacy-related news you should know before the weekend begins.

Here’s a roundup of the latest news coverage from Drug Topics®.

Antidepressant Use Can Improve Diabetes Outcomes in Patients With Depression

Patients with diabetes and depression may have a lower risk of mortality and diabetes complications when taking antidepressants regularly, according to a new study.

Read more

Efficacy, Safety of Dapagliflozin in Stage 4 Chronic Kidney Disease

Dapagliflozin was shown to significantly reduce the risk of kidney failure and prolong survival in patients with advanced chronic kidney disease regardless of diabetes status.

Read more

Study Examines High-Dose Buprenorphine Therapy in Emergency Departments

High-dose buprenorphine therapy, provided under emergency department care, is safe and well-tolerated in patients with opioid use disorder, according to study results.

Read more

US Drug Overdose Deaths Reach Record High in 2020

Drug overdose deaths, including opioid-related deaths, have increased rapidly in the United States in recent years, according to preliminary data from the CDC.

Read more

Pharmacy Groups Back Washington State Court Decision on ‘Unsustainable’ CMS Reimbursement Law

WSPA, NPCA, and NACDS fully support the court decision requiring CMS to reconsider the below-cost reimbursement plan.

Read more

AZSTARYS is now available for treating ADHD

AZSTARYS (serdexmethylphenidate and dexmethylphenidate) is available for prescription to help provide rapid and extended duration of attention-deficit/hyperactivity disorder (ADHD) symptoms.

Read more

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.